The ERK1/2 signaling pathway is involved in sulfur dioxide preconditioning-induced protection against cardiac dysfunction in isolated perfused rat heart subjected to myocardial ischemia/reperfusion

International Journal of Molecular Sciences

Volumn 14, Issue 11, 2013, Pages 22190-22201

  Huang, Pan ^a   Sun, Yan ^a   Yang, Jinyan ^a   Chen, Siyao ^a   Liu, Angie Dong ^b   Holmberg, Lukas ^b   Huang, Xiaomei ^a   Tang, Chaoshu ^c,d   Du, Junbao ^a,c   Jin, Hongfang ^a,c  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b LINKÖPING UNIVERSITY   (Sweden)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Mitogen activated protein kinase; Myocardial ischemia reperfusion injury; Preconditioning; Sulfur dioxide

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; SULFUR DIOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEART FAILURE; HEART INFARCTION PREVENTION; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ANIMALS; CARDIOTONIC AGENTS; FLAVONOIDS; HEART FAILURE; HUMANS; ISCHEMIC PRECONDITIONING; MALE; MAP KINASE SIGNALING SYSTEM; MYOCARDIUM; PHOSPHORYLATION; RATS; REPERFUSION INJURY; SULFUR DIOXIDE;

EID: 84887378231     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141122190     Document Type: Article

References (40)

1. Zhao, H.X.; Wang, X.L.; Wang, Y.H.; Wu, Y.; Li, X.Y.; Lv, X.P.; Zhao, Z.Q.; Zhao, R.R.; Liu, H.R. Attenuation of myocardial injury by postconditioning: Role of hypoxia inducible factor-1α. Basic Res. Cardiol. 2010, 105, 109-118.
2. Duan, Z.; Zhang, L.; Liu, J.; Xiang, X.; Lin, H. Early protective effect of total hypoxic preconditioning on rats against systemic injury from hemorrhagic shock and resuscitation. J. Surg. Res. 2012, 178, 842-850.
3. Gruner, C.; Akkaya, E.; Kretschmar, O.; Roffi, M.; Corti, R.; Jenni, R.; Eberli, F.R. Pharmacologic preconditioning therapy prior to atrial septal defect closure in patients at high risk for acute pulmonary edema. J. Interv. Cardiol. 2012, 25, 505-512.
4. Du, S.X.; Jin, H.F.; Bu, D.F.; Zhao, X.; Geng, B.; Tang, C.S.; Du, J.B. Endogenously generated sulfur dioxide and its vasorelaxant effect in rats. Acta Pharmacol. Sin. 2008, 29, 923-930.
5. Jin, H.F.; Du, S.X.; Zhao, X.; Wei, H.L.; Wang, Y.F.; Liang, Y.F.; Tang, C.S.; Du, J.B. Effects of endogenous sulfur dioxide on monocrotaline-induced pulmonary hypertension in rats. Acta Pharmacol. Sin. 2008, 29, 1157-1166.
6. Sun, Y.; Tian, Y.; Prabha, M.; Liu, D.; Chen, S.; Zhang, R.; Liu, X.; Tang, C.; Tang, X.; Jin, H.; et al. Effects of sulfur dioxide on hypoxic pulmonary vascular structural remodeling. Lab. Invest. 2010, 90, 68-82.
7. Li, J.; Meng, Z. The role of sulfur dioxide as an endogenous gaseous vasoactive factor in synergy with nitric oxide. Nitric Oxide 2009, 20, 166-174.
8. Liang, Y.; Liu, D.; Ochs, T.; Tang, C.; Chen, S.; Zhang, S.; Geng, B.; Jin, H.; Du, J. Endogenous sulfur dioxide protects against isoproterenol-induced myocardial injury and increases myocardial antioxidant capacity in rats. Lab. Invest. 2011, 91, 12-23.
9. Meng, Z.; Zhang, H. The vasodilator effect and its mechanism of sulfur dioxide-derivatives on isolated aortic rings of rats. Inhal. Toxicol. 2007, 19, 979-986.
10. Wang, Y.K.; Ren, A.J.; Yang, X.Q.; Wang, L.G.; Rong, W.F.; Tang, C.S.; Yuan, W.J.; Lin, L. Sulfur dioxide relaxes rat aorta by endothelium-dependent and independent mechanisms. Physiol. Res. 2009, 58, 521-527.
11. 2+ channels. Eur. J. Pharmacol. 2009, 602, 117-123.
12. Zhang, S.Q.; Du, J.B.; Jin, H.F.; Li, W.; Liang, Y.F.; Geng, B.; Li, S.K.; Zhang, C.Y.; Tang, C.S. Endogenous sulfur dioxide aggravates myocardial injury in isolated rat heart with ischemia and reperfusion. Transplantation 2009, 87, 517-524.
13. Wang, X.B.; Huang, X.M.; Ochs, T.; Li, X.Y.; Jin, H.F.; Tang, C.S.; Du, J.B. Effect of sulfur dioxide preconditioning on rat myocardial ischemia/reperfusion injury by inducing endoplasmic reticulum stress. Basic Res. Cardiol. 2011, 106, 865-878.
14. Widmann, C.; Gibson, S.; Jarpe, M.B.; Johnson, G.L. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. Physiol. Rev. 1999, 79, 143-180.
15. Gerits, N.; Kostenko, S.; Moens, U. in vivo functions of mitogen-activated protein kinases: Conclusions from knock-in and knock-out mice. Transgenic Res. 2007, 16, 281-314.
16. Cargnello, M.; Roux, P.P. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol. Mol. Biol. Rev. 2011, 75, 50-83.
17. Pang, L.; Sawada, T.; Decker, S.J.; Saltiel, A.R. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 1995, 270, 13585-13588.
18. Park, J.; Song, K.H.; Ha, H. Fractalkine increases mesangial cell proliferation through reactive oxygen species and mitogen-activated protein kinases. Transpl. Proc. 2012, 44, 1026-1028.
19. Chung, J.W.; Choi, R.J.; Seo, E.K.; Nam, J.W.; Dong, M.S.; Shin, E.M.; Guo, L.Y.; Kim, Y.S. Anti-inflammatory effects of Z-ligustilide through suppression of mitogen-activated protein kinases and nuclear factor-κB activation pathways. Arch. Pharm. Res. 2012, 35, 723-732.
20. Himaya, S.W.; Ryu, B.; Qian, Z.J.; Kim, S.K. Paeonol from Hippocampus kuda Bleeler suppressed the neuro-inflammatory responses in vitro via NF-κB and MAPK signaling pathways. Toxicol. Vitro 2012, 26, 878-887.
21. McCarroll, J.A.; Phillips, P.A.; Park, S.; Doherty, E.; Pirola, R.C.; Wilson, J.S.; Apte, M.V. Pancreatic stellate cell activation by ethanol and acetaldehyde: Is it mediated by the mitogen-activated protein kinase signaling pathway? Pancreas 2003, 27, 150-160.
22. Yang, D.; Fan, X.; Yin, P.; Wen, Q.; Yan, F.; Yuan, S.; Liu, B.; Zhuang, G.; Liu, Z. Ignification of decoy receptor 3 (DcR3) and external-signal regulated kinase 1/2 (ERK1/2) in gastric cancer patients. BMC Immunol. 2012, 13, 28.
23. Fujioka, N.; Nguyen, J.; Chen, C.; Li, Y.; Pasrija, T.; Niehans, G.; Johnson, K.N.; Gupta, V.; Kratzke, R.A.; Gupta, K. Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer. Anesth. Analg. 2011, 113, 1353-1364.
24. Bhattacharya, I.; Damjanović, M.; Dominguez, A.P.; Haas, E. Inhibition of activated ERK1/2 and JNKs improves vascular function in mouse aortae in the absence of nitric oxide. Eur. J. Pharmacol. 2011, 658, 22-27.
25. Punn, A.; Mockridge, J.W.; Farooqui, S.; Marber, M.S.; Heads, R.J. Sustained activation of p42/p44 mitogen-activated protein kinase during recovery from simulated ischaemia mediates adaptive cytoprotection in cardiomyocytes. Biochem. J. 2000, 350, 891-899.
26. Crews, C.M.; Alessandrini, A.; Erikson, R.L. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science 1992, 258, 478-480.
27. Cowley, S.; Paterson, H.; Kemp, P.; Marshall, C.J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 1994, 77, 841-852.
28. Dudley, D.T.; Pang, L.; Decker, S.J.; Bridges, A.J.; Saltiel, A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 1995, 92, 7686-7689.
29. Alessi, D.R.; Saito, Y.; Campbell, D.G.; Cohen, P.; Sithanandam, G.; Rapp, U.; Ashworth, A.; Marshall, C.J.; Cowley, S. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J. 1994, 13, 1610-1619.
30. Hausenloy, D.J.; Baxter, G.; Bell, R.; Botker, H.E.; Davidson, S.M.; Downey, J.; Heusch, G.; Kitakaze, M.; Lecour, S.; Mentzer, R.; et al. Translating novel strategies for cardioprotection: The hatter workshop recommendations. Basic Res. Cardiol 2010, 105, 677-686.
31. Koca, V.; Ari, H. Angioplasty as early revascularization in acute myocardial infarction. Anadolu. Kardiyol. Derg. 2008, 8, 77-83.
32. Yavuz, S. Surgery as early revascularization after acute myocardial infarction. Anadolu. Kardiyol. Derg. 2008, 8, 84-92.
33. Murry, C.E.; Jennings, R.B.; Reimer, K.A. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74, 1124-1136.
34. Bai, J.; Meng, Z. Expression of apoptosis-related genes in livers from rats exposed to sulfur dioxide. Toxicology 2005, 216, 253-260.
35. Balazy, M.; Abu-Yousef, I.A.; Harpp, D.N.; Park, J. Identification of carbonyl sulfide and sulfur dioxide in porcine coronary artery by gas chromatography/mass spectrometry, possible relevance to EDHF. Biochem. Biophys. Res. Commun. 2003, 311, 728-734.
36. Yue, T.L.; Wang, C.; Gu, J.L.; Ma, X.L.; Kumar, S.; Lee, J.C.; Feuerstein, G.Z.; Thomas, H.; Maleeff, B.; Ohlstein, E.H. Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ. Res. 2000, 86, 692-699.
37. Lips, D.J.; Bueno, O.F.; Wilkins, B.J.; Purcell, N.H.; Kaiser, R.A.; Lorenz, J.N.; Voisin, L.; Saba-El-Leil, M.K.; Meloche, S.; Pouysségur, J.; et al. MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. Circulation 2004, 109, 1938-1941.
38. Das, A.; Salloum, F.N.; Xi, L.; Rao, Y.J.; Kukreja, R.C. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice. Am. J. Physiol. Heart Circ. Physiol. 2009, 296, H1236-H1243.
39. Yang, X.; Liu, Y.; Yang, X.M.; Hu, F.; Cui, L.; Swingle, M.R.; Honkanen, R.E.; Soltani, P.; Tissier, R.; Cohen, M.V.; et al. Cardioprotection by mild hypothermia during ischemia involves preservation of ERK activity. Basic Res. Cardiol. 2011, 106, 421-430.
40. ATP channels. Basic Res. Cardiol. 2006, 101, 53-60.